Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress

Journal Title: Der Pharma Chemica - Year 2024, Vol 16, Issue 2

Abstract

Introduction: Triazole moiety is considered as the most important heterocyclic therapeutic agent in medicinal chemistry. Identifying a lead compound or potential drug, with the requisite physical and biological characteristics from a library of known bioactive molecules is the first step in the traditional drug development process which involves identifying the protein target associated with the disease. This severely restricts the search space from the outset and makes the task of discovering new drugs (or novel chemical structures) very challenging. Areas covered: This review discusses triazole derivatives possessing anticancer activity (hCA inhibition) and also illustrates the recent updates on triazole moiety for hCA inhibition research emphasizing the structure activity relationship aspects. Conclusion: However, as the cellular and molecular causes of numerous diseases are better understood, more opportunities for logical therapeutic development broaden. Small molecule inhibitors of hCA IX interactions can now be found through screenings using large virtual chemical libraries and a series of novel compounds from research literature. In this context, the literature's triazole benzene sulfonamide derivatives have been thoroughly studied for structure-activity relationship and reported here for future design and development of leads.

Authors and Affiliations

Papichettypalle Gopinath

Keywords

Related Articles

The Effects of Bioactive Components Derived from Fruit on Different Types of Cancer: Mechanistic Pathways and Settings Associated to Stress

Background: Cancer is the world's leading cause of death today. Cancer patients' outcomes have significantly improved as surgery, radiotherapy and pharmaceuticals have advanced. Main body: fortunately the basic mechanism...

Development and Validation of Simplified RP-HPLC Method for Quantification of Candesartan Cilexetil in Commercial Formulations

In order to produce antihypertensive effects, Candesartan Cilexetil (CC), a candesartan inactive prodrug, was quickly converted into active candesartan after absorption in the Gastrointestinal (GI) tract. This research s...

Density, Ultrasonic Velocity, Viscosity and their Excess Parameters of Some Binary Liquid Mixtures of Cumene with Aromatic Hydrocarbons at 298.15 K

Density (ρ), viscosity (η) and sound velocity (u) of binary mixtures of ethyl benzene, toluene, mesitylene with cumene have been measured over the entire range of composition at temperature 298.15 K. From the experimenta...

Curcumin and Ascorbic Acid Therapeutic Benefits in a Female Wistar Rat with Renal Tissue UVB-Induced Hyperthyroidism: A Histological and Biochemical Study

Renal issues are a major problem for humanity. The renal system may sustain damage from the potentially dangerous radiation. Therefore, the purpose of this study is to evaluate how well curcumin and ascorbic acid protect...

Requalification of Friability Testing Apparatus

Re-qualification as a part of validation is the task performed to identify or check that utilities, equipment and ancillary systems can operate within limits for their intended use. Equipment qualification is a key eleme...

Download PDF file
  • EP ID EP742509
  • DOI 10.4172/0975-413X.16.2.274-282
  • Views 15
  • Downloads 0

How To Cite

Papichettypalle Gopinath (2024). Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress. Der Pharma Chemica, 16(2), -. https://europub.co.uk./articles/-A-742509